PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshuntington disease
MeSH D006816 - huntington disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D002819:Chorea
$
Success rate
D003704:Dementia
$
Success rate
D001480:Basal ganglia diseases
0 Companies
0 Drugs
Success rate
D020271:Nervous system heredodegenerative disorders
0 Companies
0 Drugs
Success rate
D003072:Cognition disorders
0 Companies
0 Drugs
Success rate
D006816: 
Huntington disease
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanTetrabenazine Tetrabenazine  2017-01-31   
Bausch Health CompaniesTetrabenazine Xenazine  2008-08-15   
Ajanta PharmaTetrabenazine Tetrabenazine  2020-12-04   
Dr Reddys LaboratoriesTetrabenazine Tetrabenazine  2018-01-08   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
40%
8/20
Phase 2
24%
7/29
Phase 3
22%
5/23
Approved: 4Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use